Safety and pharmacokinetics of a single oral dose of amisulpride in healthy elderly volunteers.
about
Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010.Analysis of Amisulpride in Human Plasma by SPE and LC with Fluorescence Detection.Development and validation of amisulpride in human plasma by HPLC coupled with tandem mass spectrometry and its application to a pharmacokinetic study.A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer's diseaseAtypical antipsychotics: trends in analysis and sample preparation of various biological samples.Therapeutic D2/3 receptor occupancies and response with low amisulpride blood concentrations in very late-onset schizophrenia-like psychosis (VLOSLP).Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease.Update on the management of symptoms in schizophrenia: focus on amisulpride.Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder.Prandial effect on the systemic exposure of amisulpride.
P2860
Q34418688-018DB736-B8AE-4379-89F0-F51599618C79Q34538777-56964D1B-878D-4934-BE2A-63CBB95F9BFCQ35185317-F1726BF3-2860-445F-9444-ADA783EA3A70Q37184470-CDB043D7-1287-436E-A78A-F7534C112FA8Q38005440-B38310CF-0ADF-4E5B-B2ED-72429775D241Q38667647-4334DE07-409D-46AE-84F1-5A942E9C75EBQ38740848-BEF8E837-B62B-4D92-B2D8-838A24EAF1D5Q41529086-35CF1AAB-D5E9-4DC4-96EF-C000E70CDA0AQ46533503-26BCF63A-BC4B-4BBE-BDCB-858CA02EDE75Q51327838-9B471703-2268-4C0D-8D38-5D9674399074
P2860
Safety and pharmacokinetics of a single oral dose of amisulpride in healthy elderly volunteers.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Safety and pharmacokinetics of ...... in healthy elderly volunteers.
@en
Safety and pharmacokinetics of ...... in healthy elderly volunteers.
@nl
type
label
Safety and pharmacokinetics of ...... in healthy elderly volunteers.
@en
Safety and pharmacokinetics of ...... in healthy elderly volunteers.
@nl
prefLabel
Safety and pharmacokinetics of ...... in healthy elderly volunteers.
@en
Safety and pharmacokinetics of ...... in healthy elderly volunteers.
@nl
P2093
P356
P1476
Safety and pharmacokinetics of ...... in healthy elderly volunteers.
@en
P2093
Chaufour S
Chretien P
Deschamps C
Hamon-Vilcot B
Rosenzweig P
Zieleniuk I
P2888
P304
P356
10.1007/S002280050483
P577
1998-07-01T00:00:00Z